CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)
Clinical trial NCT02043665 · COMPLETED
Trial details
- NCT number
- NCT02043665
- Sponsor
- Viralytics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-18
- Primary completion
- 2020-01-10
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.